Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...
NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, October is Liver Awareness Month – how a biopsy helps diagnose liver diseases, why fatty liver disease is now on the rise, and how it can ...
Nonalcoholic fatty liver disease (NAFLD) associated with metabolic dysfunction, also known as fatty liver disease, is a disorder characterized by the accumulation of fat in the liver parenchyma that ...
Data regarding risk factors and long-term outcomes of U.S. patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. This study aimed to investigate the ...
When administered for 48 weeks, the SGLT2 inhibitor dapagliflozin alleviated steatohepatitis and fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) while demonstrating a ...
In phase 2 trials involving patients with stage 2 or 3 fibrosis caused by metabolic dysfunction–associated steatohepatitis (MASH), efruxifermin, a bivalent fibroblast growth factor 21 (FGF21) analogue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback